Eden Medical

Eden Medical

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Eden Medical is a private, pre-revenue medical technology company founded in 2019 and headquartered in South Haven, Minnesota. The company is developing a platform of non-invasive diagnostic and monitoring devices, primarily for diabetic foot wound care, to address the limitations of subjective, surface-only visual assessment. Led by founder and CEO Jeff Schoess, an experienced medical device inventor with significant NIH grant funding, the company is seeking partnerships and licensing agreements to commercialize its patented technologies. Its core value proposition is reducing the massive economic burden and poor clinical outcomes associated with chronic diabetic wounds.

Diabetic Foot UlcersWound CareOstomy Care

Technology Platform

Platform of non-invasive sensing and imaging technologies, including near-infrared spectral imaging, smart moisture/exudate mapping, and sensor-integrated wearables, for objective assessment and monitoring of wound and peristomal skin conditions.

Opportunities

The massive and growing diabetic foot ulcer market, with its $245B annual US cost and poor outcomes, presents a prime opportunity for technologies that enable prevention and improve healing.
The shift towards value-based care and remote patient monitoring creates strong demand for objective, data-driven tools that can reduce complications and costly interventions like amputations.

Risk Factors

Key risks include dependence on securing a strategic partner for commercialization, the challenge of obtaining FDA clearance and establishing reimbursement codes for novel diagnostic imaging, and the need to drive adoption in a clinical field with entrenched, subjective practices.

Competitive Landscape

Eden Medical competes in the advanced wound diagnostics space against other imaging technologies (e.g., hyperspectral imaging from companies like HyperMed Imaging, now part of Nitto Denko) and digital wound measurement apps. Its integrated approach combining prevention, imaging, and smart wearables for both wounds and ostomy care is a differentiating factor, but it faces competition from large, established wound care companies (e.g., Smith & Nephew, 3M, Mölnlycke) with extensive commercial reach.